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that extend well beyond our 
conception of normal and 
disordered musical processing. 
It provides a model that can 
be used to ask how potential 
changes at the genetic level 
impact upon brain structure 
function and, ultimately, 
behaviour. If amusia can 
be thought of as a disorder 
of connectivity, one might 
hypothesize that those genes 
which encode fibre tracking 
proteins will be found to be 
atypical. Though speculative 
at present, any such finding 
could shed light on a number of 
other developmental disorders. 
Though different development 
disorders are very different 
at the behavioural level, it 
remains possible that they 
are underpinned by a similar 
genetic mechanism operating 
at a different locus and/or at 
a different points during the 
developmental trajectory.
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Ralf Dahm
On November 3rd 1906, the young doctor Alois Alzheimer delivers a 
talk in which he describes the psychiatric symptoms and changed brain 
histology of his late patient Auguste D. This moment marks the first 
publication of what was to become one of the most infamous afflictions, 
the disease that today bears his name: Alzheimer’s disease.
Alzheimer’s discovery 
Alois Alzheimer (1864–1915) 
first encountered Auguste D. 
on November 26th, 1901. At 
that time, Alzheimer (Figure 1) 
was an assistant physician at 
the psychiatric institution in 
Frankfurt am Main. Auguste D., 
51 years old, had been admitted 
the day before by her husband. 
For eight months she had been 
developing progressive changes 
in her personality. Her memory 
started to fail her and she began 
having difficulties organising the 
household and preparing food. 
Frequently she was lost in familiar 
situations and developed a fear 
of people she knew well. She 
became unduly jealous against 
her husband and at times even 
imagined that someone wanted 
to kill her and began to shout 
wildly.
At the clinic, Auguste D. 
was spatially and temporally 
disorientated, generally 
confused, anxious and 
reluctant to cooperate with the 
institution’s personnel. When 
Alzheimer spoke with Auguste 
D., he noted that although she 
spoke clearly and articulated 
well, she often stopped mid-
sentence as if she were at a loss 
or indecisive as to whether she 
was saying the right thing. When 
reading she often pronounced 
words in a meaningless fashion 
or spelled them out letter by 
letter. Also when writing, she 
repeated syllables multiple 
times, omitted letters or entire 
syllables and generally broke off 
rapidly (Box 1).
Alzheimer had never 
encountered a patient with 
such symptoms before. He 
was fascinated by Auguste D.’s 
case and decided to examine her more closely. The Frankfurt 
institution was a congenial place 
for his studies. Its director, Emil 
Sioli, implemented innovative 
approaches for the analysis 
and treatment of psychiatric 
disorders. Interviews with 
patients were seen as an 
important means to better 
understand their afflictions and 
the study of brain pathology 
was viewed as a central tool 
in psychiatric investigations — 
approaches not widely followed 
at that time. To further these 
aims, Sioli allowed his doctors to 
devote a substantial amount of 
time to their research interests. 
To learn more about Auguste 
D.’s affliction, Alzheimer 
systematically interviewed 
her and recorded her answers 
in detailed protocols (Box 1). 
When he addressed her with 
specific questions, she often 
evaded them or her replies 
did not relate to his questions. 
When talking spontaneously, she 
frequently used paraphrases and 
inappropriate words or strings 
of words put together in wrong 
and senseless combinations. 
Generally, she named objects 
Alzheimer showed her correctly, 
but some she no longer 
recognised and did not know how 
to use them.
The case of Auguste D. as 
recorded by Alzheimer accurately 
describes the clinical symptoms 
of many patients suffering 
from Alzheimer’s disease: her 
increasingly failing memory, 
notably her early problems 
to establish memories for 
recent events; her impaired 
comprehension, unpredictable 
behaviour and psychosocial 
inaptitude; her disorientation; 
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aphasia. Overall, her symptoms fit 
the range of symptoms associated 
with Alzheimer’s disease today. 
Auguste D. herself remarked 
on her state “I have, so to say, 
lost myself ” — an apt summary 
of the tragic changes in mental 
capabilities and personality 
experienced by many patients 
suffering from Alzheimer’s 
disease.
In 1903, after 14 years, 
Alzheimer left the Frankfurt 
institution to join Emil Kraepelin, 
one of the foremost psychiatrists 
of his time, first in Heidelberg 
and later in Munich. In Munich, 
Alzheimer took over the large 
anatomical laboratory of the 
Royal Psychiatric Clinic. Under 
Alzheimer, it quickly filled with 
students and guest scientists from 
various countries. They included 
Friedrich H. Lewy, famous today 
for the Lewy bodies named after 
him, as well as Hans-Gerhard 
Creutzfeld and Alfons Maria 
Jakob who in the early 1920s first 
described the disease that now 
bears their names. Yet despite 
new tasks, Alzheimer never 
lost interest in his key case of 
Auguste D.
Over time, Auguste D.’s state 
generally worsened. She became 
more and more distant, shouting 
and showing aggression when 
being examined. Her speech 
became completely unintelligible 
and her activities increasingly 
random and meaningless. 
Eventually, she stopped talking 
altogether, only humming or 
shouting wildly, often for hours on 
end and without apparent triggers. 
In her final year, she became 
completely apathetic and spent 
most of her time hunched up 
in bed.
On April 8th 1906, five weeks 
short of her 56th birthday, 
Auguste D. died. Her brain was 
sent to Alzheimer for pathological 
examination. This gave him 
the opportunity to uncover the 
histological changes responsible 
for the symptoms he had 
observed. Alzheimer had a solid 
background in histology. During 
his studies in Würzburg, he was 
trained by Albert von Kölliker, a 
renowned histologist and pioneer 
of microscopic anatomy. Later, at the Frankfurt institution, his 
close interaction with Franz 
Nissl —famous today for the 
neuronal stain named after 
him — enhanced his proficiency 
with histological techniques. 
His expertise in histology, 
combined with the emerging 
scientific movement that tried 
to identify anatomical changes 
in the brain as a way to explain 
mental disorders, was crucial 
for Alzheimer’s discovery of the 
disease now bearing his name. 
The first anatomical and 
histological studies of Auguste 
D.’s brain already confirmed 
Alzheimer’s suspicion that this 
was an exceptional case and 
well worth pursuing further. On a 
gross anatomical level, the brain 
showed a widespread atrophy. 
Together with two visiting Italian 
physicians, Gaetano Perusini and 
Francesco Bonfiglio, Alzheimer 
meticulously examined the 
histological sections. They 
showed a massive loss of cells 
throughout the brain.
In addition to the atrophy, 
Alzheimer and his colleagues 
observed peculiar thick and 
strongly staining fibrils in the 
remaining neurons. They also 
discovered deposits of an 
unidentified substance in the 
form of plaques throughout 
the cerebral cortex. The brain 
of Auguste D. thus displayed 
what today are considered the 
histopathological hallmarks 
of Alzheimer’s disease: a loss 
of neurons as well as the 
accumulation of neurofibrillary 
tangles and amyloid plaques 
(Figure 2). To Alzheimer and 
his colleagues though, the 
findings on Auguste D.’s brain 
represented a novel and as yet 
uncharacterised pathology.
On November 3rd 1906, 
Alzheimer presented his results 
of the case of Auguste D. for 
the first time. The occasion 
was the 37th meeting of South-
West German psychiatrists in 
Tübingen, Germany. Alzheimer’s 
talk was entitled ‘On a peculiar 
disease of the cerebral cortex’. 
He began by remarking that 
the clinical manifestations of 
Auguste D. were so different 
from any other described 
disease that it was impossible to assign it to any known family of 
disorders. He then proceeded by 
recounting Auguste D.’s clinical 
symptoms and the results from 
his physical examinations of his 
patient. 
Alzheimer then described the 
analysis of Auguste D.’s brain, 
especially his findings of the 
histological sections stained 
with Bielschowsky’s silver stain. 
They displayed “very strange 
changes in the neurofibrils”, 
which clump into tangles that 
eventually replace the perished 
cells. One quarter to one third 
of all neurons in the cerebral 
cortex display such changes 
and numerous cells, particularly 
in the uppermost cell layers, 
have disappeared entirely. 
Alzheimer reported on the 
peculiar staining properties of 
these tangles and speculated that 
they had undergone a chemical 
transformation that rendered 
them different from normal 
neurofibrils.
Alzheimer then went on to 
describe the abundant ‘miliary 
foci’ (senile plaques) he had 
observed in sections of Auguste 
D.’s brain. These plaques could 
be found throughout the entire 
cerebral cortex, with the highest 
density in the uppermost layers, 
and could be discerned even 
without any staining. Alzheimer 
conjectured that they had likely 
formed by the “deposition 
of a peculiar substance”. 
Figure 1. Alois Alzheimer (1864–1915).
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Alzheimer’s first interviews with Auguste D.
Alzheimer recorded many conversations with his patients, including some with 
his most famous patient, Auguste D. The following excerpt is from an interview 
conducted with Auguste D. on November 26th 1901, one day after her admission 
to the clinic. This interview marks the beginning of scientific investigation into 
what has become known as Alzheimer’s disease. (Alzheimer’s questions in italics, 
Auguste D.’s replies in normal font.)
[She sits on the bed with a helpless expression.] What is your name? Auguste. 
Surname? Auguste. What is your husband’s name? I believe Auguste. Your 
 husband? I see, my husband… [She looks as if not having understood the 
 question.] Are you married? To Auguste. Mrs. D.? Yes, to Auguste D. How long 
have you been here? [She appears to be trying to remember.] Three weeks. 
[At lunch she eats pork and cauliflower. When asked what she is eating, she 
 replies spinach. When chewing meat and asked what it was, she answers 
 potatoes and then horseradish…]
November 29th 1901:
How are you? It is always one as the other. Who carried me here? Where are you? 
At the moment, I have temporarily, as I said, I have no means. One simply has 
to… I don’t know myself… I really don’t know… dear me, what is to then? What 
is your name? Frau Auguste D. When were you born? Eighteen hundred and… In 
which year were you born? This year, no, last year. When were you born?  Eighteen 
 hundred — I don’t know. What did I ask you? Ah, D. Auguste. […] What is your 
husband called? I don’t know. What is your husband’s name? [She answers 
quickly and as if suddenly awoken.] August Wilhelm Karl; I don’t know if I can 
state it like this. What is your husband’s profession? Clerk — I am so confused, 
so confused, I can not. […] What year is it? Eighteen hundred… Which month? 
The 2nd. […] If you buy 6 eggs, at 7 pfennig each, how much is it? To poach. 
What street do you live on here? I can tell you, I just have to wait a bit. What did 
I ask you? Well, this is Frankfurt am Main. On what street do you live? I can tell 
you, Waldemarstraße, not, no… When did you marry? I don’t know at present. 
The woman lives on the same floor. Which woman? The woman where we are 
living. [The patient calls out] Mrs Hensler, Mrs Hensler… here one step below, she 
lives. [Alzheimer shows her different objects; she names them correctly.] What 
did I show you? I don’t know… I don’t know… so anxious, so anxious. [Alzheimer 
shows her three fingers.] How many fingers? Three. Are you still anxious? Yes. 
How many fingers did I show you? Well, it is Frankfurt am Main…He concluded by reiterating 
that the pathology observed in 
Auguste D. did not fit into any 
of the categories of psychiatric 
disorders recognised at the 
time. He even speculated that 
numerous mental disorders with 
clinical symptoms deviating from 
the classical pathologies will turn 
out to be discrete pathologies 
upon histological analysis. 
Histopathological characteristics 
of the brain, he believed, would 
serve as a better basis for the 
classification of mental diseases 
than clinical symptoms.
Much to Alzheimer’s 
disappointment, there were 
no questions or discussion following his presentation. Also 
the organisers of the meeting 
considered his talk unsuitable 
for publication in the meeting 
proceedings. Only the local 
newspaper, the Tübinger Chronik, 
which covered the meeting in its 
November 5th issue, mentioned 
his talk in a single sentence: 
“Dr. Alzheimer from Munich 
reported of a peculiar, severe 
disease process which in a period 
of four and a half years causes 
a substantial loss of neurons”. 
In 1907, however, the meeting 
organisers changed their minds 
and a summary of Alzheimer’s 
talk was published. On just two 
pages, Alzheimer described the clinical and histological symptoms 
of Auguste D. (Alzheimer, A. (1907) 
Über eine eigenartige Erkrankung 
der Hirnrinde. Allgemeine 
Zeitschrift für Psychiatrie und 
Psychiatrisch-gerichtliche Medizin 
64, 146–148).
Despite the initial lack of 
recognition, Alzheimer remained 
fascinated by the peculiar disease 
and decided to examine more 
cases. Between 1907 and 1908, 
three additional patients of his 
deceased after having displayed 
symptoms very similar to those 
of Auguste D. Together with 
Perusini, Alzheimer studied 
their brains and compared 
them to the changes observed 
in Auguste D. They discovered 
that the four cases shared key 
characteristics, including the 
neurofibrillary tangles and the 
formation of plaques throughout 
the cerebral cortex. Their results, 
including the first pictures of the 
histopathological changes of 
Auguste D.’s brain, were published 
by Perusini in 1909. 
Between 1908 and 1910, 
Kraepelin worked on the 8th 
edition of his textbook on 
psychiatry. Kraepelin was one of 
the most influential psychiatrists 
of the early 20th century and his 
book was standard reading for 
psychiatrists worldwide. In the 
chapter on Senile and Presenile 
Dementias, Kraepelin introduced 
the term Alzheimer’s disease for 
the first time. He wrote “a peculiar 
group of cases with severe cellular 
changes has been described by 
Alzheimer” and went on to expertly 
summarise the clinical symptoms 
and histological abnormalities 
of this new disease. Kraepelin 
concluded his discussion of 
Alzheimer’s disease with a 
speculation on its integration 
into the spectrum of dementias 
known at the time: “The clinical 
interpretation of this Alzheimer’s 
disease is currently unclear. 
While the anatomical findings 
suggest that we are dealing with a 
particularly severe form of senile 
dementia, the fact that the disease 
occasionally begins already in 
the [patient’s] late 40s seems to 
somewhat contradict this. One 
would have to presume a Senium 
praecox [premature ageing], if it 
is maybe not indeed a peculiar 
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or less independent of age…”. 
With these speculations, Kraepelin 
seemed to anticipate that next 
to advanced age, there could be 
other factors causing an early 
onset of Alzheimer’s disease — 
genetic factors, for example, as we 
know today. 
Alzheimer himself published 
the first comprehensive account 
(Figure 3) of Auguste D.’s case 
only in 1911 (Alzheimer, A. (1911) 
Über eigenartige Krankheitsfälle 
des späteren Alters. Zeitschrift 
für die Gesamte Neurologie 
und Psychiatrie 4, 356–385). 
In this paper, he also included 
a detailed description of 
the clinical history and 
histopathology of Johann 
F., another patient who had 
displayed clinical symptoms 
similar to those of Auguste D. In 
contrast to Auguste D.’s brain, 
however, the brain of Johann F. 
lacked neurofibrillary tangles. 
With today‘s knowledge, Johann 
F. would be classified as having 
suffered from the less common 
‘plaque-only’ form of Alzheimer’s 
disease. Thus, with two patients 
published under his name, 
Alzheimer already provided 
early evidence of the range of 
pathological manifestations 
of Alzheimer’s disease known 
today. In his second article on 
the disease, Alzheimer even 
made the first steps towards 
including not only early onset 
(presenile) cases in the disease 
spectrum, but also cases of 
senile dementia showing very 
similar histological changes that 
had been observed by Alzheimer 
himself and others.
Alzheimer’s diagnosis of 
Auguste D. has since been 
confirmed by a re-examination 
of his original histological slides. 
These analyses verified the loss 
of neurons in various areas of the 
cortex as well as the presence 
of large numbers of typical 
neurofibrillary tangles and amyloid 
plaques in her cerebral cortex, 
exactly as had been described 
and depicted by Alzheimer. 
Combined with Auguste D.’s 
clinical symptoms, these data 
confirm the first described case 
of Alzheimer’s disease as being 
a typical example of the disease. Figure 2. Illustrations by Alzheimer showing neurofibrillary tangles and amyloid plaques. 
The images were included in Alzheimer’s 1911 article describing the cases of Auguste 
D. and Johann F. Similarly, the re-analysis of the 
original sections of Johann F.’s 
brain confirmed Alzheimer’s 
findings on this patient. His 
brain shows classical amyloid 
plaques in the cerebral cortex; the 
pyramidal neurons and neurites 
within the plaques, however, 
display no signs of neurofibrillary 
changes. A recent analysis of 
Johann F.’s family history revealed 
a strong familial predisposition to 
developing presenile dementia. 
Intriguingly, it has been possible 
to isolate DNA from Alzheimer’s 
original histological sections of 
both Auguste D. and Johann F.’s 
brains. To date, however, the 
analysis of this DNA has not yet 
uncovered any mutations known 
to be associated with early onset 
Alzheimer’s disease and further 
experiments with the limited 
material available will have to 
await the development of more 
sensitive technologies.
Alzheimer had wide-ranging 
interests in psychiatric disorders 
that extended well beyond the 
disease he is remembered for. 
He was a passionate scientist, 
always bound by the highest 
standards, worked very long hours and rarely took time off. 
In Munich, he worked without a 
salary over years and even paid 
a large part of the cost incurred 
by his research from his private 
funds. In 1912, his achievements 
were rewarded when he received 
an offer to become a full professor 
and director of the Psychiatric and 
Neurological Clinic at the Silesian 
Friedrich-Wilhelm-University 
in Breslau. The clinic was a 
prestigious institution at the time. 
Alzheimer succeeded scientists 
such as Heinrich Neumann, Carl 
Wernicke and most recently Karl 
Bonhoeffer. However, his relentless 
work had begun to exhaust him. 
During his move to Breslau, 
Alzheimer fell seriously ill from 
an infection, from which he never 
fully recovered. After the outbreak 
of World War I, the psychiatric 
institutions in Europe faced a wave 
of new admissions. The increased 
workload was a heavy burden 
on the weakened Alzheimer. His 
health progressively deteriorated 
and, on December 19th 1915, 
Alzheimer died aged only 51.
In his obituary, Alzheimer’s 
long-term friend and collaborator 
Nissl stressed that Alzheimer was 
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Evolution of the 
neocortex
Jon H. Kaas
Humans have exceptional skills 
and abilities that largely depend 
on their brains. One of the major 
questions of modern neuroscience 
is to understand how the human 
brain evolved. In general, we 
share brain features and functions 
with other animals in proportion 
to how closely we are related to 
them. Thus, we are more similar 
to our closest living relatives, 
chimpanzees and bonobos, than to 
more distant relatives, such as rats 
and mice, or even more distant still, 
zebrafish. As we make inferences 
about the evolution of the human 
brain, or any other complex brain, 
such as elephant or whale brains, 
from studies of other animals, 
we benefit from an increasing 
understanding of phylogeny and 
thus our relationships to other 
animals. 
Tracing the course of human 
brain evolution
The first question in tracing 
the course of human brain 
evolution is how far back to 
start. We could start with the 
first nervous systems that 
emerged with the evolution of 
multicellular life forms, or the 
early bilateral nervous system 
that insects and vertebrates 
share, but that inverted with 
respect to the dorsoventral body 
axis in vertebrates compared to 
insects. However, for the present 
discussion, it is practical to start 
with early mammals, and focus 
on the neocortex, a part of the 
brain that was greatly modified 
from the thin dorsal cortex of 
reptiles to form the thicker, layered 
neocortex of mammals. As a 
result of over 200 million years 
of divergent evolution, the over 
4600 species of extant mammals 
now vary greatly in overall brain 
size, and especially the amount 
of neocortex. The human brain 
in particular is dominated by two 
very large, highly convoluted 
Primer sheets of neocortex, the most enlarged part of the human brain. 
There are at least four 
complementary approaches we 
can use to determine the course of 
forebrain and neocortex evolution 
from early mammals to humans. 
One is to compare the brains of 
extant mammals and assume that 
features or characteristics held 
in common have been retained 
from a common ancestor. Today, 
this comparative approach usually 
involves a cladistic character 
analysis, and several formal 
procedures have been described. 
In brief, any group of mammals 
that have descended from a 
common ancestor forms a clade, 
and features (characters) held 
in common are parsimoniously 
attributed to that common 
ancestor. Thus, if we consider the 
clade of humans and our closest 
living relatives, the bonobos 
and chimpanzees, then brain 
features we share are likely to 
have been retained from the 
common ancestor of humans, 
bonobos and chimpanzees. If we 
consider the clade that includes 
all mammals, then features widely 
present in mammals across the 
major branches of the mammalian 
radiation are likely to have been 
retained from the first mammals. 
The usefulness of this approach 
depends on how much we 
know about the brains of extant 
mammals.
A second approach is to study 
the fossil record. Because the soft 
tissue of brains does not fossilize, 
this record does not tell us anything 
about the internal organization of 
brains. However, skulls do fossilize, 
and the internal brain case of 
the skulls of mammals conforms 
closely to the size and shape of the 
brain. Thus, endocasts of the brain 
cases can reveal the size, shape, 
and even folding patterns in the 
cortex of the brains of long extinct 
mammals. Brain size — especially 
in relation to body size — is an 
important guide to brain computing 
power and intelligence, while 
differences in brain shape suggest 
differences in the sizes of functional 
compartments of the brain. Finally, 
the pattern of cerebral fissures 
apparent in the endocasts can 
suggest the locations of functional 
divisions of cortex.more than an outstanding scientist 
who contributed greatly to our 
knowledge of the histopathology 
of various brain diseases. He was 
“first and foremost a psychiatrist 
who strove to advance psychiatry 
by using a microscope”. Contrary 
to the growing movement that 
regarded disabled people as 
inferior, Alzheimer treated his 
patients with great compassion.
Today, Alzheimer’s name 
is associated with one of the 
cruellest diseases and the mere 
mention of his name conjures 
up associations of inexorable 
mental decline. However, it 
was his genuine interest in the 
troubles of his patients and his 
discovery of the pathological 
basis of the disease that paved 
the way to a better understanding 
of the processes underlying 
Alzheimer’s disease. These 
fundamental discoveries will no 
doubt contribute to any future 
treatments for the affliction. A 
century after Alzheimer’s first 
description of the disease, 
the growing number of elderly 
individuals worldwide makes 
the need for such treatments 
increasingly pressing. 
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Figure 3. Drawings of neurofibrillary tan-
gles by Alzheimer and published in his 
1911 paper.
